Neogen Corp (NEOG)
12.02
-0.44
(-3.53%)
USD |
NASDAQ |
May 03, 16:00
12.26
+0.24
(+2.00%)
After-Hours: 20:00
Neogen Price to Book Value: 0.8275 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 0.8578 |
| May 01, 2024 | 0.8434 |
| April 30, 2024 | 0.8489 |
| April 29, 2024 | 0.8551 |
| April 26, 2024 | 0.8358 |
| April 25, 2024 | 0.8234 |
| April 24, 2024 | 0.8516 |
| April 23, 2024 | 0.8475 |
| April 22, 2024 | 0.811 |
| April 19, 2024 | 0.7993 |
| April 18, 2024 | 0.8214 |
| April 17, 2024 | 0.8358 |
| April 16, 2024 | 0.8372 |
| April 15, 2024 | 0.8269 |
| April 12, 2024 | 0.8523 |
| April 11, 2024 | 0.895 |
| April 10, 2024 | 0.8606 |
| April 09, 2024 | 0.8978 |
| April 08, 2024 | 0.99 |
| April 05, 2024 | 0.988 |
| April 04, 2024 | 0.9694 |
| April 03, 2024 | 0.9818 |
| April 02, 2024 | 0.9976 |
| April 01, 2024 | 1.038 |
| March 28, 2024 | 1.086 |
| Date | Value |
|---|---|
| March 27, 2024 | 1.064 |
| March 26, 2024 | 1.033 |
| March 25, 2024 | 1.046 |
| March 22, 2024 | 1.047 |
| March 21, 2024 | 1.064 |
| March 20, 2024 | 1.074 |
| March 19, 2024 | 1.040 |
| March 18, 2024 | 1.038 |
| March 15, 2024 | 1.045 |
| March 14, 2024 | 1.050 |
| March 13, 2024 | 1.075 |
| March 12, 2024 | 1.096 |
| March 11, 2024 | 1.115 |
| March 08, 2024 | 1.127 |
| March 07, 2024 | 1.154 |
| March 06, 2024 | 1.152 |
| March 05, 2024 | 1.154 |
| March 04, 2024 | 1.187 |
| March 01, 2024 | 1.184 |
| February 29, 2024 | 1.184 |
| February 28, 2024 | 1.178 |
| February 27, 2024 | 1.188 |
| February 26, 2024 | 1.160 |
| February 23, 2024 | 1.167 |
| February 22, 2024 | 1.184 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7993
Minimum
Apr 19 2024
6.405
Maximum
Apr 20 2021
3.869
Average
4.802
Median
Apr 20 2020
Price to Book Value Benchmarks
| Moderna Inc | 3.454 |
| Regeneron Pharmaceuticals Inc | 4.047 |
| Syros Pharmaceuticals Inc | 8.145 |
| Disc Medicine Inc | 2.130 |
| Amylyx Pharmaceuticals Inc | 0.3183 |
Price to Book Value Related Metrics
| PE Ratio | 2084.27 |
| PS Ratio | 2.802 |
| Price | 12.02 |
| Earnings Yield | 0.05% |
| Market Cap | 2.604B |
| Operating PE Ratio | 37.71 |
| Normalized PE Ratio | 571.86 |